The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ELCC 2019 | Treatment sequecing strategies in advanced NSCLC

Name: Treatment sequecing strategies in advanced NSCLC
Duration: 1 min 14 s
Description: Martin Reck, MD, PhD, from Lung Clinic Grosshansdorf, Grosshansdorf, Germany, explains recent changes and sequencing strategies in non-mutated, non-squamous advanced non-small cell lung cancer (NSCLC). This interview took place at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland.

Martin Reck • 12 Apr 2019

ELCC 2019

Lung Cancer Non-Small Cell Lung Cancer Nintedanib Ramucirumab

Martin Reck, MD, PhD, from Lung Clinic Grosshansdorf, Grosshansdorf, Germany, explains recent changes and sequencing strategies in non-mutated, non-squamous advanced non-small cell lung cancer (NSCLC). This interview took place at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland.